QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stifel-maintains-hold-on-core-laboratories-lowers-price-target-to-12

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $13 to $12.

 citigroup-maintains-neutral-on-core-laboratories-lowers-price-target-to-13

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $16 to...

 core-laboratories-sees-q2-gaap-eps-017-021-vs-024-est-sees-sales-128000m-134000m-vs-13601m-est

Core Laboratories (NYSE:CLB) is looking for Q2 GAAP EPS of $0.17-$0.21 vs $0.24 analyst estimate. sees sales of $128.000 millio...

 core-laboratories-q1-adj-eps-014-misses-019-estimate-sales-12358m-miss-12980m-estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.1...

 stifel-maintains-hold-on-core-laboratories-lowers-price-target-to-15

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $19 to $15.

 citigroup-upgrades-core-laboratories-to-neutral-raises-price-target-to-16

Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral and raises the price target from $...

 citigroup-maintains-sell-on-core-laboratories-raises-price-target-to-15

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and raises the price target from $14 to $15.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION